Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Birrer

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Early events in the pathogenesis of epithelial ovarian cancerCharles N Landen, Michael J Birrer, Anil K Sood
Cancer|January 23, 2020
Biomarkers in ovarian cancer: To be or not to beRebecca Arend, Alba Martinez, Tomasz Szul, et al.
The Oncologist|March 22, 2019
Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing PracticeLeslie M Randall, Michael J Birrer, Thomas J Herzog
Cancers|May 17, 2019
Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian CancerBrandon M Roane, Rebecca C Arend, Michael J Birrer
Molecular Biology International|May 2, 2012
RASSF1A and the Taxol Response in Ovarian CancerSusannah Kassler, Howard Donninger, Michael J Birrer, et al.
Journal of Psychosocial Oncology|January 15, 2025
Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trialMei Bai, David Cella, Sangchoon Jeon, et al.
Plos One|July 3, 2013
p21-activated kinase 3 (PAK3) is an AP-1 regulated gene contributing to actin organisation and migration of transformed fibroblastsNina Holderness Parker, Howard Donninger, Michael J Birrer, et al.
Journal of Psychosocial Oncology|November 19, 2025
An alternative perspective on the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12 item Scale (FACIT-Sp-12) in people newly diagnosed with advanced cancerMei Bai, David Cella, Sangchoon Jeon, et al.
The Oncologist|January 13, 2019
Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?Michael J Birrer, Ilaria Betella, Lainie P Martin, et al.
Journal of the National Cancer Institute|March 13, 2019
Antibody-Drug Conjugate-Based Therapeutics: State of the ScienceMichael J Birrer, Kathleen N Moore, Ilaria Betella, et al.
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Early events in the pathogenesis of epithelial ovarian cancerCharles N Landen, Michael J Birrer, Anil K Sood
Cancer|January 23, 2020
Biomarkers in ovarian cancer: To be or not to beRebecca Arend, Alba Martinez, Tomasz Szul, et al.
The Oncologist|March 22, 2019
Ovarian Cancer Maintenance: Practice-Changing Data Calls for Changing PracticeLeslie M Randall, Michael J Birrer, Thomas J Herzog
Cancers|May 17, 2019
Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian CancerBrandon M Roane, Rebecca C Arend, Michael J Birrer
Molecular Biology International|May 2, 2012
RASSF1A and the Taxol Response in Ovarian CancerSusannah Kassler, Howard Donninger, Michael J Birrer, et al.
Journal of Psychosocial Oncology|January 15, 2025
Self-affirmation intervention for patients newly diagnosed with advanced cancer: a preliminary efficacy trialMei Bai, David Cella, Sangchoon Jeon, et al.
Plos One|July 3, 2013
p21-activated kinase 3 (PAK3) is an AP-1 regulated gene contributing to actin organisation and migration of transformed fibroblastsNina Holderness Parker, Howard Donninger, Michael J Birrer, et al.
Journal of Psychosocial Oncology|November 19, 2025
An alternative perspective on the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12 item Scale (FACIT-Sp-12) in people newly diagnosed with advanced cancerMei Bai, David Cella, Sangchoon Jeon, et al.
The Oncologist|January 13, 2019
Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?Michael J Birrer, Ilaria Betella, Lainie P Martin, et al.
Journal of the National Cancer Institute|March 13, 2019
Antibody-Drug Conjugate-Based Therapeutics: State of the ScienceMichael J Birrer, Kathleen N Moore, Ilaria Betella, et al.
Pageof 23